The platform addresses fragmented biopharma R&D procurement by streamlining supplier qualification, compliance enforcement, vendor matching, automated contract drafting, and predictive project modeling. Companies achieve double-digit cost savings while cutting project timelines from months to days.

“Scientist.com is a category-defining platform that transforms how biopharma companies manage R&D procurement, seamlessly integrating software, data, and outsourced services,” said Edward de Nor and Stuart QUIN, Partners at GHO. “We are excited to partner with the team to expand global adoption and advance innovation.”

Kevin Lustig, Andy Martin, and Chris Petersen, Founders of Scientist.com, added: “GHO’s expertise across our key market segments and track record of scaling innovative leaders make them the ideal partner to help us scale globally. Together, we can put outsourced R&D ‘on rails’, delivering shorter timelines, stronger governance, and clearer visibility from concept to clinic.”